MV Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BIP
MV Capital Management's TAK Position: Q2 2026 in Review
MV Capital Management reduced its Takeda Pharmaceutical (TAK) stake by 1.6% in Q2 2026, selling an estimated $50 and leaving 179 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #734.
MV Capital Management first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.37K in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- MV Capital Management held 179 shares of Takeda Pharmaceutical worth $2.87K as of Q2 2026.
- MV Capital Management sold 3 Takeda Pharmaceutical shares in Q2 2026, an estimated $50.
- Takeda Pharmaceutical made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #734 holding.
- MV Capital Management first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
- MV Capital Management's Takeda Pharmaceutical position peaked at $3.37K in Q1 2026.
- 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.